Granting stock options to directors and executive officers
First written in FY2019-Q1. 3 of 6 entries say "Advanced", first in FY2019. Latest entry: FY2023.
The whole theme swung hardest in 2021: 4 of 33 companies on the "Worse" side.
9 other companies' latest entry also says "Dropped".
- FY2023DroppedAnnual report
「The Company discontinued its stock option plan after introducing a restricted stock compensation plan from the fiscal year ending March 2023. Accordingly, no stock options have been granted since the fiscal year ending March 2023.」
The stock option plan for directors and executive officers was discontinued, and the Company transitioned to a restricted stock compensation plan. - FY2022-Q2AdvancedAnnual report
「Date of resolution 5 August 2021 Class and number of grantees (people) Company directors 3; executive officers 12 Company executive fellows 2 Number of stock acquisition rights (rights)* 2,228 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 222,800 Exercise period for stock acquisition rights* 21 August 2021 to 20 August 2051」
Based on the resolution of 5 August 2021, 2,228 stock acquisition rights were granted to directors, executive officers and executive fellows, representing 222,800 underlying shares. - FY2020AdvancedAnnual report
「Date of resolution 3 April 2020 Class and number of grantees (people) Company directors 3; executive officers 14 Number of stock acquisition rights (rights) 4,738 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares) Common shares 473,800 Exercise period for stock acquisition rights 18 April 2020 to 17 April 2050」
On 3 April 2020, before the filing date, 4,738 stock options were granted to 3 directors and 14 executive officers, representing 473,800 underlying shares. - FY2020-Q1RestatedAnnual report
「Date of resolution 5 April 2019 Class and number of grantees (people) Company directors 4; executive officers 14 Number of stock acquisition rights (rights) 2,209 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 220,900 Exercise period for stock acquisition rights* 23 April 2019 to 22 April 2049」
The 2,209 stock acquisition rights, 220,900 underlying shares and exercise period for the stock options for directors and executive officers approved on 5 April 2019 continued to be disclosed. - FY2019AdvancedAnnual report
「Date of resolution 5 April 2019 Class and number of grantees (people) Company directors 4; executive officers 14 Number of stock acquisition rights (rights) 2,209 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares) Common shares 220,900 Exercise period for stock acquisition rights* 23 April 2019 to 22 April 2049」
Based on the resolution of 5 April 2019, 2,209 stock acquisition rights were granted to 4 directors and 14 executive officers, representing 220,900 underlying shares. - FY2019-Q1First statedAnnual report
「Date of resolution 6 April 2018 Class and number of grantees (people) Company directors 5; executive officers 15 Number of stock acquisition rights (rights)* 1,218 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 121,800 Exercise period for stock acquisition rights* 24 April 2018 to 23 April 2048」
Based on the resolution of 6 April 2018, 1,218 stock acquisition rights were granted to 5 directors and 15 executive officers, representing 121,800 underlying shares, with an exercise period from 24 April 2018 to 23 April 2048.